fludarabine and Bone Marrow Failure Syndromes, Congenital

fludarabine has been researched along with Bone Marrow Failure Syndromes, Congenital in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's1 (50.00)2.80

Authors

AuthorsStudies
Abujoub, R; Alafghani, S; Aldaama, S; Almanjomi, F; Alsudairy, R; Alsultan, A; Ballourah, W; Essa, MF; Jarrar, MS; Memon, S1
Bajwa, RP; Rose, MJ; Woods, G1

Reviews

1 review(s) available for fludarabine and Bone Marrow Failure Syndromes, Congenital

ArticleYear
Reduced intensity transplantation for congenital amegakaryocytic thrombocytopenia: report of a case and review of the literature.
    Pediatric transplantation, 2014, Volume: 18, Issue:1

    Topics: Alemtuzumab; Antibodies, Monoclonal, Humanized; Blood Platelets; Congenital Bone Marrow Failure Syndromes; Female; Hematopoietic Stem Cell Transplantation; Hepatic Veno-Occlusive Disease; Humans; Infant; Melphalan; Methylprednisolone; Mucositis; Neutrophils; Thrombocytopenia; Transplantation Conditioning; Vidarabine

2014

Other Studies

1 other study(ies) available for fludarabine and Bone Marrow Failure Syndromes, Congenital

ArticleYear
Human leucocyte antigen-matched related haematopoietic stem cell transplantation using low-dose cyclophosphamide, fludarabine and thymoglobulin in children with severe aplastic anaemia.
    British journal of haematology, 2023, Volume: 203, Issue:2

    Topics: Anemia, Aplastic; Antilymphocyte Serum; Child; Congenital Bone Marrow Failure Syndromes; Cyclophosphamide; DNA Helicases; Fanconi Anemia; Female; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Histocompatibility Antigens Class II; HLA Antigens; Humans; Male; Transplantation Conditioning

2023